Table 2. Univariate analysis of prognostic factors for OS.
Covariate | n | Hazard ratio | 95% CI | P-value for OS |
---|---|---|---|---|
Age (years) | ||||
<70 | 54 | 0.984 | 0.448–2.160 | 0.968 |
⩾70 | 15 | |||
Gender | ||||
Male | 58 | 0.456 | 0.161–1.291 | 0.139 |
Female | 11 | |||
Effect of CRT | ||||
Effective | 49 | 0.207 | 0.104–0.413 | 0.0001*** |
Not effective | 20 | |||
Lymph-node metastasis | ||||
Positive | 31 | 3.567 | 1.751–7.266 | 0.0001*** |
Negative | 38 | |||
Distant metastasis | ||||
Positive | 13 | 4.064 | 2.016–8.192 | 0.0001*** |
Negative | 56 | |||
Depth of tumour invasion | ||||
T3 | 40 | 0.383 | 0.195–0.751 | 0.005* |
T4 | 29 | |||
Tumour location a | ||||
Upper | 10 | 1.139 | 0.442–2.934 | 0.787 |
Lower | 59 | |||
Gli-1 expression | ||||
Nuclear | 7 | 4.115 | 1.676–10.104 | 0.002** |
Others | 62 |
CI=confidence interval; CRT=chemoradiotherapy; Gli-1=glioma-associated oncogene homologue 1; OS=overall survival.
*P<0.01; **P<0.005; ***P<0.0005.
Upper or lower, above or below the tracheal bifurcation.